2009 Annual Meeting - Fast Forward and Beyond
June 11-12, 2009

Kennebunkport, ME




Plenary Session II – Strategic Initiatives



LaSalle  D. Leffall, Jr., MD, FACS
Howard University Cancer Center
Chair, C-Change Board of Directors

Co-Chair’s Address
President George H. W. Bush


Business Report

Strategic Initiatives Progress Report
-James Marks, MD, MPH, Robert Wood Johnson Foundation
Vice-Chair, C-Change Board of Directors,
Chair, Mission Strategy, and Implementation Committee

Membership Report

-Gary Reedy, Johnson & Johnson
Secretary, C-Change Board of Directors
Chair, Membership Committee

Recognition of Service – Board of Directors

-Harold P. Freeman, MD, Ralph Lauren Cancer Center
-Robert A. Ingram, GlaxoSmithKline
-LaSalle D. Leffall, Jr, MD, FACS, Howard University Cancer Center

Recognition of Service – Membership Committee

-Gary Reedy, Johnson & Johnson, Chair
-Philip Huang, MD, MPH, Austin/Travis County Health & Human Services Department
-Gerard T. Kennealey, MD, Cephalon Inc.
-Gabriel Leung, PharmD, OSI Pharmaceuticals

Finances / Resource Acquisition Report
-Cheryl G. Healton, DrPH, MPA, American Legacy Foundation, Treasurer, C-Change Board of Directors

Executive Director’s Report / Membership Survey Findings

-Tom Kean, MPH, C-Change


Longer-term Opportunities
-Moderated by John R. Seffrin, PhD, American Cancer Society
Emeritus Board Member, C-Change

-Anna D. Barker, PhD, National Cancer Institute - Realizing a Future of Personalized Cancer Medicine: Future Challenges for Cancer
Patient Access Perspectives
-Hala Moddelmog, Susan G. Komen for the Cure

Summary Remarks
-John R. Seffrin, PhD

Closing Remarks
-LaSalle D. Leffall, Jr., MD, FACS 


















2009 Annual Meeting
Program Book